Magnetically controlled protein nanocontainers as a drug depot for the hemostatic agent

References

• Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012;157(2):168–182. doi:10.1016/j.jconrel.2011.07.03121839127
   PubMed Web of Science ®Google Scholar
• Sponton OE, Perez AA, Carrara CR, Santiago LG. Linoleic acid binding properties of ovalbumin nanoparticles. Colloids Surf B Biointerfaces. 2015;128:219–226. doi:10.1016/j.colsurfb.2015.01.03725701117
   PubMed Web of Science ®Google Scholar
• Jun JY, Nguyen HH, Chun HS, Kang BC, Ko S. Preparation of size-controlled bovine serum albumin (BSA) nanoparticles by a modified desolvation method. Food Chem. 2011;127(4):1892–1898. doi:10.1016/j.foodchem.2011.02.040
   Web of Science ®Google Scholar
• Langer K, Balthasar S, Vogel V, Dinauer N, Von Briesen H, Schubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm. 2003;257(1–2):169–180.12711172
   PubMed Web of Science ®Google Scholar
• Zhong Q, Minfeng J. Zein nanoparticles produced by liquid–liquid dispersion. Food Hydrocoll. 2009;23(8):2380–2387. doi:10.1016/j.foodhyd.2009.06.015
   Web of Science ®Google Scholar
• Estrada LH, Chu S, Champion JA. Protein nanoparticles for intracellular delivery of therapeutic enzymes. J Pharm Sci. 2014;103(6):1863–1871. doi:10.1002/jps.2397424740820
   PubMed Web of Science ®Google Scholar
• Gendler E, Gendler S, Nimni ME. Toxic reactions evoked by glutaraldehyde‐fixed pericardium and cardiac valve tissue bioprosthesis. J Biomed Mater Res. 1984;18(7):727–736. doi:10.1002/jbm.8201807036085799
   PubMed Web of Science ®Google Scholar
• Dreis S, Rothweiler F, Michaelis M, JJr C, Kreuter J, Langer K. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Int J Pharm. 2007;341(1–2):207–214. doi:10.1016/j.ijpharm.2007.03.03617478065
   PubMed Web of Science ®Google Scholar
• Von Storp B, Engel A, Boeker A, Ploeger M, Langer K. Albumin nanoparticles with predictable size by desolvation procedure. J Microencapsul. 2012;29(2):138–146. doi:10.3109/02652048.2011.63521822329480
   PubMed Web of Science ®Google Scholar
• Champion JA, Katare YK, Mitragotri S. Particle shape: a new design parameter for micro-and nanoscale drug delivery carriers. J Control Release. 2007;121(1–2):3–9. doi:10.1016/j.jconrel.2007.03.02217544538
   PubMed Web of Science ®Google Scholar
• Taheri A, Dinarvand R, Atyabi F, et al. Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with luteinizing hormone-releasing hormone (LHRH) peptide. Int J Mol Sci. 2011;12(7):4591–4608. doi:10.3390/ijms1207459121845098
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang G, Lin X, et al. Polyethylenimine‐coated albumin nanoparticles for BMP‐2 delivery. Biotechnol Prog. 2008;24(4):945–956. doi:10.1002/btpr.1219194903
   PubMed Web of Science ®Google Scholar
• Han Y, Shchukin D, Yang J, Simon CR, Fuchs H, Möhwald H. Biocompatible protein nanocontainers for controlled drugs release. ACS Nano. 2010;4(5):2838–2844. doi:10.1021/nn100307j20394391
   PubMed Web of Science ®Google Scholar
• Piradashvili K, Fichter M, Mohr K, Gehring S, Wurm FR, Landfester K. Biodegradable protein nanocontainers. Biomacromolecules. 2015;16(3):815–821. doi:10.1021/bm501691525619361
   PubMed Web of Science ®Google Scholar
• Ferraris VA, Brown JR, Despotis GJ. Update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91(3):944–982. doi:10.1016/j.athoracsur.2010.11.07821353044
   PubMed Web of Science ®Google Scholar
• Björses K, Holst J. Various local hemostatic agents with different modes of action; an in vivo comparative randomized vascular surgical experimental study. Eur J Vasc Endovasc Surg. 2007;33(3):363–370. doi:10.1016/j.ejvs.2006.10.01117137801
   PubMed Web of Science ®Google Scholar
• Alpaslan C, Alpaslan GH, Oygur T. Tissue reaction to three subcutaneously implanted local hemostatic agents. Br J Oral Maxillofac Surg. 1997;35(2):129–132.9146872
   PubMed Web of Science ®Google Scholar
• Petersen JK, Krogsgaard J, Nielsen KM, Nørgaard EB. A comparison between 2 absorbable hemostatic agents: gelatin sponge (Spongostan®) and oxidized regenerated cellulose (Surgicel®). Int J Oral Surg. 1984;13(5):406–410.6209233
   PubMedGoogle Scholar
• Romanò CL, Monti L, Logoluso N, Romanò D, Drago L. Does a thrombin-based topical hemostatic agent reduce blood loss and transfusion requirements after total knee revision surgery? A randomized, controlled trial. Knee Surg Sports Traumatol Arthrosc. 2015;23(11):3337–3342. doi:10.1007/s00167-014-3153-825011643
   PubMed Web of Science ®Google Scholar
• Marano L, Di Martino N. Efficacy of human fibrinogen-thrombin patch (TachoSil) clinical application in upper gastrointestinal cancer surgery. J Invest Surg. 2016;29(6):352–358. doi:10.1080/08941939.2016.118122927191688
   PubMed Web of Science ®Google Scholar
• Huang F, Wu D, Ma G, Yin Z, Wang Q. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res. 2014;186(1):318–327. doi:10.1016/j.jss.2013.08.02024075404
   PubMed Web of Science ®Google Scholar
• Peters A, Verma K, Slobodyanyuk K, et al. Antifibrinolytics reduce blood loss in adult spinal deformity surgery: a prospective, randomized controlled trial. Spine. 2015;40(8):443–449. doi:10.1097/BRS.000000000000078525599286
   PubMed Web of Science ®Google Scholar
• Alkjaersig N, Fletcher AP, Sherry S. E-aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem. 1959;234:832–837.13654273
   PubMed Web of Science ®Google Scholar
• Ipema HJ, Tanzi MG. Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures. Ann Pharmacother. 2012;46(1):97–107. doi:10.1345/aph.1Q38322202494
   PubMed Web of Science ®Google Scholar
• Tengborn L, Blombäck M, Berntorp E. Tranexamic acid–an old drug still going strong and making a revival. Thromb Res. 2015;135(2):231–242. doi:10.1016/j.thromres.2014.11.01225559460
   PubMed Web of Science ®Google Scholar
• Anastasova EI, Prilepskii AY, Fakhardo AF, Drozdov AS, Vinogradov VV. Magnetite nanocontainers: toward injectable highly magnetic materials for targeted drug delivery. ACS Appl Mater Interfaces. 2018;10(36):30040–30044. doi:10.1021/acsami.8b1012930137958
   PubMed Web of Science ®Google Scholar
• Drozdov AS, Vinogradov VV, Dudanov IP, Vinogradov VV. Leach-proof magnetic thrombolytic nanoparticles and coatings of enhanced activity. Sci Rep. 2016;6:28119. doi:10.1038/srep2811927321930
   PubMed Web of Science ®Google Scholar
• Drozdov AS, Vinogradov VV. Magnetic thrombolytic ceramic nanoparticles. Mater Today Proc. 2017;4(7):6856–6862. doi:10.1016/j.matpr.2017.07.014
   Google Scholar
• Weber C, Coester C, Kreuter J, Langer K. Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm. 2000;194(1):91–102.10601688
   PubMed Web of Science ®Google Scholar
• Prilepskii AY, Fakhardo AF, Drozdov AS, et al. Urokinase-conjugated magnetite nanoparticles as a promising drug delivery system for targeted thrombolysis: synthesis and preclinical evaluation. ACS Appl Mater Interfaces. 2018;10(43):36764–36775. doi:10.1021/acsami.8b1479030299938
   PubMed Web of Science ®Google Scholar
• Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28–51. doi:10.1016/j.addr.2015.09.01226456916
   PubMed Web of Science ®Google Scholar
• Wu J, Zhao C, Lin W, et al. Binding characteristics between polyethylene glycol (PEG) and proteins in aqueous solution. J Mater Chem B. 2014;2(20):2983–2992. doi:10.1039/c4tb00253a
   PubMed Web of Science ®Google Scholar
• Cruje C, Chithrani DB. Polyethylene glycol density and length affects nanoparticle uptake by cancer cells. J Nanomed Res. 2014;1(1):00006.
   Google Scholar
• Goldenberg NA, Hathaway WE, Jacobson L, Manco-Johnson MJ. A new global assay of coagulation and fibrinolysis. Thromb Res. 2005;116(4):345–356. doi:10.1016/j.thromres.2004.12.00916038720
   PubMed Web of Science ®Google Scholar